JUL 16, 2017 10:00 AM PDT

Research on Neurological Tumor Development Reveals Drug Target

WRITTEN BY: Carmen Leitch

Scientists have learned more about the role of a molecule called prion protein (PrPC) in the development of some types of neurological tumors. This work could have a huge impact on the treatment of several cancerous diseases, like breast cancer, melanoma, glioblastoma, mesothelioma, and neurofibromatosis 2 (NF2), a hereditary genetic disorder carried by thousands of people.

This is a schwannoma tumor cell. / Credit: University of Plymouth

NF2 causes tumor growth on the nervous system. These tumors - ependymomas, schwannomas, and meningiomas - have been associated with mutations in the tumor suppressor gene Merlin. The researchers discovered that a deficiency of Merlin is linked to the overproduction of PrPC in schwannoma compared with healthy Schwann cells. This work, by investigators at the University of Plymouth and Plymouth Hospitals NHS Trust, has been reported in Oncogene.

Normally, the PrPC protein is important during embryonic development and acts in neuroprotection in healthy adults. However, it is absent in patients with Creutzfeldt-Jakob prion disease that carry a deleterious variant of a prion protein - scrapie prion protein (PrPSc). There are elevated levels of PrPC in several cancers like breast, gastric and prostate cancer and glioblastoma.

The scientists have also identified a number of existing drugs that might be useful for reducing protein production. Because these drugs have been approved already for the treatment of Acute Myeloid Leukemia (AML), Creutzfeldt-Jakob disease, and multiple myeloma, it could be relatively straightforward to orchestrate clinical studies for repurposing them.

"By understanding the relationship between overproduction of PrPC and Merlin deficiency in the development of schwannoma and meningioma, we have made a significant stride forward in the search for a drug treatment for NF2. This is a life-changing condition usually striking the young. That our discovery could also lead to hope for thousands of patients affected by other Merlin-deficient tumors, adds yet more to the significance and excitement of our findings,” commented Dr. Sylwia Ammoun, Senior Research Fellow in Clinical Neurobiology.

"Identifying a range of existing drugs which could be repurposed is an exciting approach by which we can speed up the progress of scientific discovery from the lab to the clinic, without compromising safety. Brain tumors kill more children and adults under the age of 40 than any other cancer, but a lack of research funding over decades has meant that current treatments lag well behind those of leukemia and many other cancers. We are having to play catch up to improve outcomes for patients and this study will bring us closer to identifying new and effective therapies,” noted Dr. Kieran Breen, Director of Research at Brain Tumor Research.

Check out the video above to learn more about both types of neurofibromatosis.

Sources: AAAS/Eurekalert! Via University of Plymouth, Oncogene

About the Author
  • Experienced research scientist and technical expert with authorships on over 30 peer-reviewed publications, traveler to over 70 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
APR 25, 2021
Genetics & Genomics
It's DNA Day!
APR 25, 2021
It's DNA Day!
The genetic instructions that biological organisms use to generate their structures & maintain life are contained in a m ...
APR 25, 2021
Microbiology
Plant-Eating Microbes Expand the Tree of Life
APR 25, 2021
Plant-Eating Microbes Expand the Tree of Life
After microbes called archaea were discovered in the 1970s, a branch was added to the tree of life after some debate, wh ...
MAY 15, 2021
Drug Discovery & Development
New Drug Blocks Critical Step in Malaria Life Cycle
MAY 15, 2021
New Drug Blocks Critical Step in Malaria Life Cycle
According to the World Health Organization (WHO), in 2019, there were approximately 229 million cases of malaria around ...
MAY 30, 2021
Microbiology
The Mechanics of a Gliding Microbe, Revealed
MAY 30, 2021
The Mechanics of a Gliding Microbe, Revealed
Humans have been able to use machines to master movement, but there are many organisms that can get around just fine on ...
MAY 31, 2021
Microbiology
How a Retrovirus Can Turn Infectious
MAY 31, 2021
How a Retrovirus Can Turn Infectious
This image by Martin Obr, PhD of IST Austria shows a structure called a capsid that shields viral genetic material and h ...
JUN 14, 2021
Microbiology
Researchers Identify a Novel, Beneficial Bacterium
JUN 14, 2021
Researchers Identify a Novel, Beneficial Bacterium
Since researchers were able to use genetic technologies to reveal how important the gut microbiome is to human health, t ...
Loading Comments...